Lazard Asset Management’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,565
Closed -$49K 2332
2025
Q2
$49K Buy
5,565
+5,247
+1,650% +$31.1K ﹤0.01% 2012
2025
Q1
$1K Sell
318
-144
-31% -$979 ﹤0.01% 2270
2024
Q4
$3K Sell
462
-537
-54% -$4.42K ﹤0.01% 2172
2024
Q3
$9K Buy
999
+363
+57% +$3.75K ﹤0.01% 2033
2024
Q2
$6K Buy
636
+526
+478% +$5.6K ﹤0.01% 2060
2024
Q1
$0 Buy
+110
New +$895 ﹤0.01% 2387

Other funds holding ULBI

Lazard Asset Management's ULBI Position: Q3 2025 in Review

Lazard Asset Management sold out of Ultralife (ULBI) in Q3 2025, closing a stake of 5,565 shares — an estimated $49K sold.

Lazard Asset Management first reported a position in ULBI in Q1 2024 and held it in 6 quarters. The position peaked at $49K in Q2 2025. 63 funds tracked by Wall St. Rank hold ULBI as of Q3 2025.

  • Lazard Asset Management reported no remaining Ultralife position as of Q3 2025 after selling out during the quarter.
  • Lazard Asset Management sold 5,565 Ultralife shares in Q3 2025, an estimated $49K.
  • Lazard Asset Management first reported a position in Ultralife in Q1 2024 and held it in 6 quarters.
  • Lazard Asset Management's Ultralife position peaked at $49K in Q2 2025.
  • 63 funds tracked by Wall St. Rank held Ultralife as of Q3 2025.

Based on Lazard Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.